NCGC00138783 free base is a selective inhibitor targeting CD47/SIRPα axis, with an IC 50 of 50 µM. NCGC00138783 free base directly blocks the interaction between CD47 and SIRPα axis.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > CD47
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.